Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Prog Neuropsychopharmacol Biol Psychiatry
2010 Mar 17;342:376-86. doi: 10.1016/j.pnpbp.2010.01.004.
Show Gene links
Show Anatomy links
Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?
Savić MM, Majumder S, Huang S, Edwankar RV, Furtmüller R, Joksimović S, Clayton T, Ramerstorfer J, Milinković MM, Roth BL, Sieghart W, Cook JM.
???displayArticle.abstract???
Over the last years, genetic studies have greatly improved our knowledge on the receptor subtypes mediating various pharmacological effects of positive allosteric modulators at GABA(A) receptors. This stimulated the development of new benzodiazepine (BZ)-like ligands, especially those inactive/low-active at GABA(A) receptors containing the alpha(1) subunit, with the aim of generating more selective drugs. Hereby, the affinity and efficacy of four recently synthesized BZ site ligands: SH-053-2'N, SH-053-S-CH3-2'F, SH-053-R-CH3-2'F and JY-XHe-053 were assessed. They were also studied in behavioral tests of spontaneous locomotor activity, elevated plus maze, and water maze in rats, which are considered predictive of, respectively, the sedative, anxiolytic, and amnesic influence of BZs. The novel ligands had moderately low to low affinity and mild to partial agonistic efficacy at GABA(A) receptors containing the alpha(1) subunit, with variable, but more pronounced efficacy at other BZ-sensitive binding sites. While presumably alpha(1) receptor-mediated sedative effects of GABA(A) modulation were not fully eliminated with any of the ligands tested, only SH-053-2'N and SH-053-S-CH3-2'F, both dosed at 30 mg/kg, exerted anxiolytic effects. The lack of clear anxiolytic-like activity of JY-XHe-053, despite its efficacy at alpha(2)- and alpha(3)-GABA(A) receptors, may have been partly connected with its preferential affinity at alpha(5)-GABA(A) receptors coupled with weak agonist activity at alpha(1)-containing subtypes. The memory impairment in water-maze experiments, generally reported with BZ site agonists, was completely circumvented with all four ligands. The results suggest that a substantial amount of activity at alpha(1) GABA(A) receptors is needed for affecting spatial learning and memory impairments, while much weaker activity at alpha(1)- and alpha(5)-GABA(A) receptors is sufficient for eliciting sedation.
Baldwin,
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
2005, Pubmed
Baldwin,
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
2005,
Pubmed Bandelow,
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.
2008,
Pubmed Berezhnoy,
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite.
2008,
Pubmed
,
Xenbase Bohlhalter,
Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study.
1996,
Pubmed Buccafusco,
Spatial Navigation (Water Maze) Tasks
2009,
Pubmed Cain,
Testing the NMDA, long-term potentiation, and cholinergic hypotheses of spatial learning.
1998,
Pubmed Choudhary,
Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
1992,
Pubmed Cruz,
Ethopharmacological analysis of rat behavior on the elevated plus-maze.
1994,
Pubmed de Haas,
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
2007,
Pubmed Dias,
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines.
2005,
Pubmed Fuchs,
Endogenous [3H]flunitrazepam binding in human embryonic kidney cell line 293.
1995,
Pubmed Garner,
Research in anxiety disorders: from the bench to the bedside.
2009,
Pubmed Grimwood,
Target site occupancy: emerging generalizations from clinical and preclinical studies.
2009,
Pubmed Hadingham,
Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors.
1993,
Pubmed Kralic,
GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem.
2002,
Pubmed Lippa,
Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
2005,
Pubmed
,
Xenbase Löw,
Molecular and neuronal substrate for the selective attenuation of anxiety.
2000,
Pubmed Markou,
Removing obstacles in neuroscience drug discovery: the future path for animal models.
2009,
Pubmed McNamara,
Diazepam impairs acquisition but not performance in the Morris water maze.
1991,
Pubmed Minier,
Positioning of the alpha-subunit isoforms confers a functional signature to gamma-aminobutyric acid type A receptors.
2004,
Pubmed
,
Xenbase Mirza,
NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
2008,
Pubmed Pike,
Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
2007,
Pubmed Pirker,
GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.
2000,
Pubmed Popik,
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
2006,
Pubmed
,
Xenbase Rivas,
Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models.
2009,
Pubmed Rodgers,
Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.
1995,
Pubmed Rudolph,
GABA-based therapeutic approaches: GABAA receptor subtype functions.
2006,
Pubmed Rudolph,
Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
1999,
Pubmed Sanna,
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
2002,
Pubmed
,
Xenbase Savić,
The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats.
2009,
Pubmed Savić,
Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
2004,
Pubmed Savić,
Benzodiazepine site inverse agonists and locomotor activity in rats: bimodal and biphasic influence.
2006,
Pubmed Savić,
Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?
2008,
Pubmed
,
Xenbase Savić,
PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.
2008,
Pubmed
,
Xenbase Sigel,
Properties of single sodium channels translated by Xenopus oocytes after injection with messenger ribonucleic acid.
1987,
Pubmed
,
Xenbase Sigel,
The effect of subunit composition of rat brain GABAA receptors on channel function.
1990,
Pubmed
,
Xenbase van Rijnsoever,
Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice.
2004,
Pubmed Vorhees,
Morris water maze: procedures for assessing spatial and related forms of learning and memory.
2006,
Pubmed Wang,
Simple and sensitive liquid chromatography/tandem mass spectrometry method for the determination of diazepam and its major metabolites in rat cerebrospinal fluid.
2003,
Pubmed Whiting,
GABA-A receptors: a viable target for novel anxiolytics?
2006,
Pubmed Wieland,
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
1992,
Pubmed Yamada,
Molecular basis for the GABAA receptor-mediated tonic inhibition in rat somatosensory cortex.
2007,
Pubmed
